130 related articles for article (PubMed ID: 6383778)
1. [Glucose tolerance and insulin secretion in relation to age in type-II diabetes--a contribution to the pathogenesis of type-II diabetes mellitus].
Verlohren HJ; Lohmann D
Dtsch Z Verdau Stoffwechselkr; 1984; 44(2):77-8. PubMed ID: 6383778
[TBL] [Abstract][Full Text] [Related]
2. [Insulin resistance and insulin secretion in type II non-obese diabetics].
Pelikánová T; Válek J; Kazdová L; Saudek F; Karasová L
Cas Lek Cesk; 1994 Mar; 133(6):172-6. PubMed ID: 8156572
[TBL] [Abstract][Full Text] [Related]
3. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
4. [The role of gastrin in regulating insulin and glucagon secretion in patients with diabetes mellitus].
Starosel'tseva LK; Kniazeva AP; Belovalova IM; Abduraimova GR
Probl Endokrinol (Mosk); 1988; 34(4):20-5. PubMed ID: 3057484
[TBL] [Abstract][Full Text] [Related]
5. Insulin secretion in type II diabetics: in vivo and in vitro investigation.
Verlohren HJ; Jahr H
Exp Clin Endocrinol; 1984 Apr; 83(2):216-24. PubMed ID: 6373323
[TBL] [Abstract][Full Text] [Related]
6. Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus.
Henry RR; Brechtel G; Griver K
J Clin Endocrinol Metab; 1988 May; 66(5):979-86. PubMed ID: 3283164
[TBL] [Abstract][Full Text] [Related]
7. [Characteristics of insulin secretion in persons with glucose tolerance disorders and in patients with type II diabetes mellitus].
Starosel'tseva LK; Gonzales R; Perich R; Rodriges B; Klaro A
Probl Endokrinol (Mosk); 1983; 29(5):3-8. PubMed ID: 6359133
[TBL] [Abstract][Full Text] [Related]
8. [Insulin therapy of obese diabetic patients? Consequences for the evaluation of insulin secretion and metabolic behavior].
Verlohren HJ; Danneberg G; Brunner E; Pohl A; Bierwolf B
Dtsch Z Verdau Stoffwechselkr; 1987; 47(6):311-25. PubMed ID: 3129276
[TBL] [Abstract][Full Text] [Related]
9. Insulin secretion in insulin-requiring diabetics before and during insulin treatment.
Enk B
Acta Endocrinol (Copenh); 1977 Jul; 85(3):559-70. PubMed ID: 577340
[TBL] [Abstract][Full Text] [Related]
10. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.
Scheen AJ; Castillo MJ; Lefèbvre PJ
Diabetes Metab; 1996 Dec; 22(6):397-406. PubMed ID: 8985647
[TBL] [Abstract][Full Text] [Related]
11. Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations.
Nyholm B; Walker M; Gravholt CH; Shearing PA; Sturis J; Alberti KG; Holst JJ; Schmitz O
Diabetologia; 1999 Nov; 42(11):1314-23. PubMed ID: 10550415
[TBL] [Abstract][Full Text] [Related]
12. [Pathogenesis of diabetes in adulthood. I. Insulin secretion at different evolutionary phases of diabetes].
Andreev D; Turkolev N
Vutr Boles; 1978; 17(3):9-17. PubMed ID: 354214
[TBL] [Abstract][Full Text] [Related]
13. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
[TBL] [Abstract][Full Text] [Related]
14. [And what about diabetes?].
Cerasi E
Bull Acad Natl Med; 2007; 191(4-5):941-3; discussion 943. PubMed ID: 18225448
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of insulin response in relatives of type-I and type-II diabetics.
Schulz B; Ratzmann KP; Michaelis D
Exp Clin Endocrinol; 1984 May; 83(3):327-33. PubMed ID: 6381072
[TBL] [Abstract][Full Text] [Related]
16. Impaired incretin secretion and pancreatic dysfunction with older age and diabetes.
Geloneze B; de Oliveira Mda S; Vasques AC; Novaes FS; Pareja JC; Tambascia MA
Metabolism; 2014 Jul; 63(7):922-9. PubMed ID: 24854384
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-stimulated insulin secretion in patients with type 2 diabetes mellitus: support for the concept of glucose toxicity.
Wolffenbuttel BH; Menheere PP; Nijst L; Rondas-Colbers GJ; Sels JP; Nieuwenhuijzen Kruseman AC
Neth J Med; 1992 Jun; 40(5-6):277-82. PubMed ID: 1436266
[TBL] [Abstract][Full Text] [Related]
18. Serum magnesium in insulin-dependent diabetics and healthy subjects in relation to insulin secretion and glycemia during glucose-glucagon test.
Menzel R; Pusch H; Ratzmann GW; Besch W; Förster F; Albrecht G; Ruhnke R
Exp Clin Endocrinol; 1985 Feb; 85(1):81-8. PubMed ID: 3886415
[TBL] [Abstract][Full Text] [Related]
19. [Pathogenesis of diabetes in adulthood. II. The nature of the insulin secretory defect].
Andreev D; Turkolev N
Vutr Boles; 1978; 17(3):17-24. PubMed ID: 676292
[TBL] [Abstract][Full Text] [Related]
20. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
